chelsearx.com
3530 Toringdon Way Suite 200 Charlotte, NC 28277, US
Chelsea Therapeutics
Chelsea Therapeutics was a biopharmaceutical company specializing in the development of innovative products that addressed important unmet medical needs or offered alternatives to existing treatments. Chelsea's novel medication, Northera (droxidopa) for symptomatic neurogenic orthostatic hypotension was approved by the FDA in February 2014. The company was acquired by Lundbeck in June 2014.
Chelsea Therapeutics
Chelsea Therapeutics was a biopharmaceutical company specializing in the development of innovative products that addressed important unmet medical needs or offered alternatives to existing treatments. Chelsea's novel medication, Northera (droxidopa) for symptomatic neurogenic orthostatic hypotension was approved by the FDA in February 2014. The company was acquired by Lundbeck in June 2014.
chelsearx.com
3530 Toringdon Way Suite 200 Charlotte, NC 28277, US
Details
Year founded
2004
Revenue
5M-10M
Employees
11-50
Number of locations
1
NAICS
3254
SIC
2834
Products & Services
Outlines the company's specialized services and operational strengths.
- Biopharmaceuticals
- Neurologic disorders treatment
- Pharmaceuticals
- Contact us in order to access
Equipment
Provides a detailed list of machinery and tools utilized on the company's premises.
- The Back Attack™
- Leverage Mid Row
- Standing Chest Press Machine
- Contact us in order to access
Ramping up production
Indicates the company's current production trend and growth trajectory.
FALSE
Our production algorithm is showing that chelsea therapeutics is not ramping up production.
Target industries
Locations (1)
Chelsea Therapeutics
3530 Toringdon Way Suite 200 Charlotte, NC 28277, US
Frequently Asked Questions
What services & capabilities does Chelsea Therapeutics offer?
Chelsea Therapeutics offers a range of services and capabilities, including Biopharmaceuticals.
What kind of equipment does Chelsea Therapeutics use?
Chelsea Therapeutics uses a variety of equipment, including The Back Attack™.
What are the target industries of Chelsea Therapeutics?
Chelsea Therapeutics serves several industries, including the medical industry.
How many locations does Chelsea Therapeutics operate?
Chelsea Therapeutics operates from a single location at 3530 toringdon way suite 200, charlotte, north carolina 28277, united states.
Where are the headquarters of Chelsea Therapeutics?
The headquarters of Chelsea Therapeutics are located in 3530 toringdon way suite 200, charlotte, north carolina 28277, united states.
What is the NAICS code for Chelsea Therapeutics?
The NAICS code for Chelsea Therapeutics is 3254.
How many employees does Chelsea Therapeutics have?
Chelsea Therapeutics has 12 employees.
What is the official website of Chelsea Therapeutics?
The official website of Chelsea Therapeutics is https://www.chelsearx.com/.
When was Chelsea Therapeutics founded?
Chelsea Therapeutics was founded in 2004.